StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Precigen price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Precigen's price to sales ratio was 19.7× on Nov 11, 2026, against 20.2× a year earlier. Over the last 5 years it ranged from 3.8× to 152.0×, with a median of 15.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202619.7×+6.7
2023Oct 31, 202313.1×+2.1
2022Dec 30, 202211.0×−4.1
2021Dec 31, 202115.0×−3.0
2020Dec 31, 202018.1×+10.3
2019Dec 31, 20197.8×+3.0
2018Dec 31, 20184.8×−2.2
2017Dec 29, 20176.9×−8.5
2016Dec 30, 201615.4×−6.1
2015Dec 31, 201521.5×−36.2
2014Dec 31, 201457.7×−41.9
2013Dec 31, 201399.6×–

More Precigen figures

See a number that looks wrong?